Login to Your Account



Pharma: Other News To Note


Monday, June 3, 2013

• Shire plc, of Dublin, settled litigation against Teva Pharmaceuticals USA Inc., a division of Teva Pharmaceutical Industries Ltd., of Jerusalem, related to Teva's abbreviated new drug application for a generic version of Shire's Intuniv (guanfacince) for attention deficit hyperactivity disorder.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription